Skip to content

CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms

CT Radiomic Features of Pancreatic Neuroendocrine Neoplasms

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03967951
Enrollment
70
Registered
2019-05-30
Start date
2019-03-23
Completion date
2019-05-06
Last updated
2019-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Neuroendocrine Tumor

Keywords

Radiomics, Pancretic neuroendocrine neoplasms (panNEN)

Brief summary

The aim of this study is to quantify inter-observer variability in delineating pancreatic neuroendocrine neoplasm (PanNEN) on Computerized Tomography (CT) images and its impact on radiomic features (RF), subsequently to this determination, to use CT texture analysis to predict, histological characteristics of PanNEN on CT scans.

Detailed description

CT imaging is the most widely used modality for studying radiomic features due to its ability to assess tissue density, shape, texture and size before, during and after therapy. To the best of the investigator's knowledge, the impact of inter-observer delineation variability on the reliability of CT RF for PanNEN patients, including Hounsfield unit (HU) values-, shape-, and texture-based features, has not yet been assessed. One this has been determined, an additional evaluation will be conducted to correlate the morphologically observed images with their histopathological characteristics. The ultimate potential objective of this research is to identify and predict characteristics of aggressiveness of PanNEN in CT scans.

Interventions

OTHERCT radiomic feature evaluation

Radiomic features will be calculated and extracted from all contrast and non-contrast CT-scans. First order features will be evaluated and high order features will be grouped in parent matrices. Parent matrices of second and third order will be chosen and evaluated. In the second part, based on the results of inter-correlation of the operator analysis, the most significant radiomic features will be chosen. Morphological and histopathological features will be evaluated will be. Histopathology will be performed on a biopsy specimen; percentage of Ki67 and grading will be evaluated.

Sponsors

Francesco De Cobelli
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* \> 18 years of age * pancreatic neuroendocrine neoplasm with intervention and biopsy * availability of pre-operatory CT scan with or without IV contrast agent- inInstitution from 2009-2017

Exclusion criteria

* pregnant women

Design outcomes

Primary

MeasureTime frameDescription
Interobserver variability in delineating panNENs on CT6 monthsAsses inter-observer variability on CT- scans (with contrast alone)

Secondary

MeasureTime frameDescription
Use CT texture analysis to predict, histological characteristics of PanNEN on CT scans6 monthsEvaluate histological characteristics on CT-scans with and without contrast agent in a group of subjects

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026